Loading...
This record has been deleted. Since it is linked to a published record, it is available here for reference purposes only.
Click here to view the deleted recordThis document has been updated. This is not the latest published version. Click here to view the latest version of the record.
Biosafety Virtual Library Resources
(VLR)
last updated: 12 Sep 2024
Biosafety Technical Series 06: Legislative Study on Biosafety Mainstreaming
EN
-
Organization:
The Secretariat of the Convention on Biological Diversity
(SCBD)
|
BCH-CON-SCBD-101430-1
Organization:The Secretariat of the Convention on Biological Diversity (SCBD)UN and other specialized agency of the UN Common System413 Saint-Jacques Street, Suite 800Montreal, QC
H2Y 1N9, CanadaPhone: +1 514 288 2220,Fax: +1 514 288 6588,Email: secretariat@cbd.int,Website: https://www.cbd.int,
Secretariat of the Convention on Biological Diversity
EN
2024-09
EN
© 2024, Secretariat of the Convention on Biological Diversity
EN
- CBD Biosafety Technical Series 06 [ English ]
The present legislative study on the mainstreaming of biosafety was commissioned by the Secretariat of the Convention on Biological Diversity.1 In the present study, the term “biosafety mainstreaming” refers to the integration of biosafety in domestic cross-sectoral and sectoral legislation, policies and institutional frameworks, taking into account national circumstances
and priorities. Through in-depth analysis
of international and national laws and policies and
domestic examples of biosafety mainstreaming, the
study provides a comprehensive overview of biosafety
obligations and the practical ways in which biosafety
measures can be mainstreamed into the national
laws, policies and institutional frameworks of the
Parties to the Cartagena Protocol on Biosafety to
the Convention on Biological Diversity,2 the Nagoya-
Kuala Lumpur Supplementary Protocol on Liability
and Redress to the Cartagena Protocol on Biosafety3
and the Convention on Biological Diversity. This
legislative study aims at assisting Parties in achieving
the integrated implementation of the Cartagena
Protocol. Its target audience may include both those
engaged, at the national level, in the development and implementation of biosafety-related legislation,
and those engaged in the development and implementation
of cross-sectoral and sectoral policies and
laws that are indirectly relevant to biosafety.
EN
- GBF-T17. Strengthen biosafety and distribute benefits of biotechnology
No
No
No